
Interview with Carmen Jacobson and Manda Wood from CARTI Cancer Center
We spoke with Carmen and Manda about a typical day in the practice, their experience with the new Drug Substitution feature and more.
We’re partnering with cancer centers to deliver a better patient experience, strengthen practice health, and close the gap between care and research.
We spoke with Carmen and Manda about a typical day in the practice, their experience with the new Drug Substitution feature and more.
We spoke with Olivia Barrett about her experience with Flatiron Assist, data reporting at her practice, the Oncology Medical Home pilot program and more.
We spoke with Kailee Hawkins about time-saving OncoTrials™ features, the Prospective Clinico-Genomic study that her practice is involved in and more.
We spoke with Pamela about tips that help practice administrators, the new Genomic Profiling Integration with Foundation Medicine, upcoming OncoEMR® features and more.
We spoke with Heather about networking between different oncology practices, her experience with the revamped Visit Documentation workflow, and more.
We spoke with Vivien about the regimen workflow process at Flatiron, how OncoEMR is designed from a clinician’s point of view, and more.
We spoke with Kahiya Jackson and Kurt Campbell about situations that specifically affect smaller practices, tips that help them succeed in their role, the benefits and advantages of smaller practices and more.
We spoke with Rachel De La Rosa about her start in community oncology, the new tumor assessments feature in OncoEMR®, the experience of beta testing a new feature, and more.
We spoke with Dr. Iuliana Shapira about how COVID affected her practice, the way the government gets involved in electronic health records and the advice she has for us on improving CareSpace.
We spoke with Anne Slam about the biggest challenges facing practice administrators, what it takes to keep a healthy practice running, why RCM services seem threatening and more.
We spoke with Dr. Ted Arrowsmith about the benefits of centrally managed regimens, the difference between OncoEMR® and hospital systems, the dream of robust decision support and more.